Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

A HicA toxin-based counter-selection marker for allelic exchange mutations in Fusobacterium nucleatum

View through CrossRef
ABSTRACT The study of fusobacterial virulence factors has dramatically benefited from the creation of various genetic tools for DNA manipulation, including the galK-based counterselection for in-frame deletion mutagenesis in Fusobacterium nucleatum that was recently developed. However, this method requires a host lacking the galK gene, which is an inherent limitation. To circumvent this limitation, we explored the possibility of using the hicA gene that encodes a toxin consisting of a HicAB toxin-antitoxin module in Fusobacterium periodonticum as a new counter-selective marker. Interestingly, the full-length hicA gene is not toxic in F. nucleatum , but a truncated hicA gene version lacking the first six amino acids is functional as a toxin. The toxin expression is driven by an rpsJ promoter and is controlled at its translational level using a theophylline-responsive riboswitch unit. As a proof of concept, we created markerless in-frame deletions in the fusobacterial adhesin RadD gene within the F. nucleatum rad operon and the tnaA gene that encodes the tryptophanase for indole production. After vector integration, plasmid excision after counterselection appeared to have occurred in 100% of colonies grown on theophylline-added plates and resulted in in-frame deletions in 50% of the screened isolates. This hicA -based counterselection system provides a robust and reliable counterselection in wild-type background F. nucleatum and should also be adapted for use in other bacteria. IMPORTANCE Fusobacterium nucleatum is an indole-producing human oral anaerobe associated with periodontal diseases, preterm birth, and several cancers. Little is known about the mechanisms of fusobacterial pathogenesis and associated factors mainly due to the lack of robust genetic tools for this organism. Here we showed that a mutated hicA gene from Fuosbacterium periodonticum expresses an active toxin and was used as a counterselection marker. This hicA -based in-frame deletion system efficiently creates in-frame deletion mutations in the wild-type background of F. nucleatum . This is the first report to use the hicA gene as a counterselection marker in a bacterial genetic study.
Title: A HicA toxin-based counter-selection marker for allelic exchange mutations in Fusobacterium nucleatum
Description:
ABSTRACT The study of fusobacterial virulence factors has dramatically benefited from the creation of various genetic tools for DNA manipulation, including the galK-based counterselection for in-frame deletion mutagenesis in Fusobacterium nucleatum that was recently developed.
However, this method requires a host lacking the galK gene, which is an inherent limitation.
To circumvent this limitation, we explored the possibility of using the hicA gene that encodes a toxin consisting of a HicAB toxin-antitoxin module in Fusobacterium periodonticum as a new counter-selective marker.
Interestingly, the full-length hicA gene is not toxic in F.
nucleatum , but a truncated hicA gene version lacking the first six amino acids is functional as a toxin.
The toxin expression is driven by an rpsJ promoter and is controlled at its translational level using a theophylline-responsive riboswitch unit.
As a proof of concept, we created markerless in-frame deletions in the fusobacterial adhesin RadD gene within the F.
nucleatum rad operon and the tnaA gene that encodes the tryptophanase for indole production.
After vector integration, plasmid excision after counterselection appeared to have occurred in 100% of colonies grown on theophylline-added plates and resulted in in-frame deletions in 50% of the screened isolates.
This hicA -based counterselection system provides a robust and reliable counterselection in wild-type background F.
nucleatum and should also be adapted for use in other bacteria.
IMPORTANCE Fusobacterium nucleatum is an indole-producing human oral anaerobe associated with periodontal diseases, preterm birth, and several cancers.
Little is known about the mechanisms of fusobacterial pathogenesis and associated factors mainly due to the lack of robust genetic tools for this organism.
Here we showed that a mutated hicA gene from Fuosbacterium periodonticum expresses an active toxin and was used as a counterselection marker.
This hicA -based in-frame deletion system efficiently creates in-frame deletion mutations in the wild-type background of F.
nucleatum .
This is the first report to use the hicA gene as a counterselection marker in a bacterial genetic study.

Related Results

20 ELUCIDATING THE ROLE OF FUSOBACTERIUM NUCLEATUM IN INTESTINAL INFLAMMATION
20 ELUCIDATING THE ROLE OF FUSOBACTERIUM NUCLEATUM IN INTESTINAL INFLAMMATION
Abstract Background While the direct cause of inflammatory bowel disease (IBD) is unknown, the gut microbiota is speculated to p...
Fusobacterium nucleatum triggers proinflammatory cell death via Z-DNA binding protein 1 in apical periodontitis
Fusobacterium nucleatum triggers proinflammatory cell death via Z-DNA binding protein 1 in apical periodontitis
Abstract Background Z-DNA binding protein 1 (ZBP1) is a vital innate immune sensor that regulates inflammation during pathogen invasion. ZBP1 may co...
Investigation of the antibacterial effects of hinokitiol on Fusobacterium nucleatum
Investigation of the antibacterial effects of hinokitiol on Fusobacterium nucleatum
Hinokitiol (HNK), which is known to have stress-relieving properties in living organisms and to show antimicrobial activity against both bacteria and fungi, has been used as a form...
Fusobacterium nucleatum Promotes the Progression of Colorectal Cancer Through Cdk5-Activated Wnt/β-Catenin Signaling
Fusobacterium nucleatum Promotes the Progression of Colorectal Cancer Through Cdk5-Activated Wnt/β-Catenin Signaling
Background/AimsGrowing evidence supports the direct link of Fusobacterium nucleatum with colorectal cancer (CRC). However, to date, the underlying mechanism of action remains poorl...

Back to Top